TRATAMIENTO

Therapeutics and COVID-19 July 2021

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION)_an open-label, multicentre, randomised, controlled trial June 2021

Anticoagulation in COVID-19: reaction to the ACTION trial June 2021

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the rophylaxis and Treatment of COVID-19 May - June 2021

Therapy with RAS inhibitors during the COVID-19 pandemic May 2021

COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital March 2021

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines February 2021

Remdesivir approved to treat COVID-19 amid controversy January 2021

Effect of Remdesivir vs Standard C are on Clinical Status at 11 Days in Patients With Moderate COVID-19 September 2020

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 October 2020

Chloroquine and Hydroxychloroquine, With or Without Azithromycin, for COVID-19: A Brief Overview October 2020

Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome September 2020

Clinical Outcomes Associated with Methylprednisolone in Mechanically Ventilated Patients with COVID-19 August 2020

COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence? July 2020

A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline July 2020

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report July 2020

Effect of Colchicine vs Standard Care o n Cardiac and Inflammatory Biomarkers

and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019

The GRECCO-19 Randomized Clinical Trial June 2020

Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic A Proposed Algorithm June 2020

Urgent Guidan ce for Navigating and Circumventing the QTc-Prolonging and

Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease

19 (COVID-19) June 2020

The Urgency of Care during the Covid-19 Pandemic — Learning as We Go June 2020

How to Discover Antiviral Drugs Quickly June 2020

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy May 2020

Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology May 2020

A human monoclonal antibody blocking SARS-CoV-2 infection May 2020

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial May 2020

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

May 2020

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review May 2020

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 April 2020

COVID-19 and the RAAS—a potential role for angiotensin II? April 2020

A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19 April 2020

Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19 April 2020

Type and dose of heparin in COVID-19 April 2020

The trinity of COVID-19: immunity, inflammation and intervention April 2020

Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) April 2020

Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines April 2020

COVID-19: Immunology and treatment options April 2020

Ongoing Clinical Trials for the Management of the COVID-19 Pandemic April 2020

Safety considerations with chloroq uine, hydroxychloroquine and azithromycin in the

management of SARS-CoV-2 infection April 2020

Treatment of 5 Critically Ill Patients WithCOVID-19 With Convalescent Plasma April 2020

COVID-19 Treatment: A Review of Early and Emerging Options April 2020

The versatile heparin in COVID-19 March 2020

Treatment of COVID-19: old tricks for new challenges March 2020

Experimental Treatment with Favipiravir for COVID-19: An Open-Label

Control Study March 2020

Usefulness of Ivermectin in COVID-19 Illness March 2020

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy March 2020

ACE2 the Janus-faced protein – from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19 March 2020

ACE2 the Janus-faced protein - from card.

Descargar • 389KB

The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro

March 2020

No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection

March 2020

The versatile heparin in COVID-19 March 2020

Of chloroquine and COVID-19 March 2020

¿Cuál es la eficacia de la hidroxicloroquina en el tratamiento de la COVID-19?

Marzo 2020

COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression March 2020

Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? February 2020

Is Hydroxychloroquine a possible post-exposure prophylaxis drug to limit the transmission to health care workers exposed to COVID19? March 2020